NewsBlaze logo
Newsletter logo   Search News     Daily News   

Pharmaceutical

Alcon, Inc. and its partner, NovaBay Pharmaceuticals, Inc. , announced today that Alcon has begun treating patients in a Phase 2 clinical trial of NovaBay's patented lead Aganocide compound, NVC-422, for viral conjunctivitis, a type of "pink eye&quo
4 hours ago
A la suite de la publication ce matin d'un communiqué et d'une procédure subséquente devant la Cour supérieure du Québec, Adaltis Inc. , société internationale de tests diagnostiques in vitro, a annoncé aujourd'hui qu'elle a obtenu une ordonnance
54 hours ago
Further to a news release issued this morning and the completion of subsequent proceedings before the Quebec Superior Court, Adaltis Inc. , an international in vitro diagnostic company, today announced that it has obtained an Order for creditor protectio
54 hours ago
ALDA Pharmaceuticals Corp. announces that it is undertaking a non-brokered private placement of up to 3 million units of the Company at a price of $0.20 per Unit for proceeds to the Company of up to $600,000. Each Unit consists of one common share of ALD
55 hours ago
Ramsy Darwish knows what it's like being addicted to prescription pain medication. In a recent story called America's "Other" Drug Problem Prescription Medication Abuse with CNN's Rick Sanchez, Ramsy shared his story of addiction and recovery a
56 hours ago
In groundbreaking research, scientists at the University of North Texas Health Science Center at Fort Worth have determined that rapid estrogen administration can protect the brain following brain injury. These findings are now being tested on human trau
58 hours ago
InterSystems provides first integrated system to support acute, community and social careEton, UK - 3rd July 2009 - InterSystems Corporation yesterday announced that the States of Jersey Health and Social Services Department has selected InterSystems Tra
61 hours ago
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
61 hours ago
BioCis Pharma Ltd., a privately held drug development company with its headquarters in Turku, Finland , announced positive results from its Phase IIa clinical trial of ProtoCure emulsion cream, the company's novel topical drug for dermatology. This doubl
62 hours ago
Sundia MediTech, a leading integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China announced today that Dr. Chen Chen has been appointed Senior Vice President of Chemistry Services.
63 hours ago
Allosteric modulation company Addex Pharmaceuticals invites investors, analysts, media and other interested parties to attend its annual R&D day on Thursday, July 16, 2009 in Geneva, Switzerland.
63 hours ago
ThromboGenics NV and co-development partner BioInvent International announce that they have started recruitment of a second cohort of patients for their Phase II trial of TB-402. This follows completion of recruitment of the first cohort of 100 patients
68 hours ago
Stem Cell Therapeutics Corp. is pleased to announce an early warrant exercise incentive program designed to encourage the early exercise of up to 17,250,000 outstanding share purchase warrants for gross proceeds of up to $2,760,000. The Program will be o
3 days ago
A new analysis of the incidence of breast cancer in Italy per 100,000 women between the ages of 0 to 84 from 2000 to 2005 shows a 72 percent spike above official estimates issued by the Ministry of Health, with the sharpest uptick of +28.6 percent found
3 days ago
a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.
3 days ago

1 - 15 of 57954 Stories
<<  <   Next 15 Pharmaceutical   > >>


NewsBlaze 

Copyright © 2004-2009 NewsBlaze LLC
Use of this website is subject to our Terms of Service and Privacy Policy       Support    Press Room